• Explore /
  • Poster
  • / Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study.

Recombinant humanized anti-PD-1 monoclonal antibody (JS001) as salvage treatment for advanced esophageal squamous cell carcinoma: Preliminary results of an open-label, multi-cohort, phase Ib/II clinical study.

Abstract Poster

Authors

Rui-Hua Xu

Rui-hua Xu

Sun Yat-sen University Cancer Center, Guangzhou, China

Rui-hua Xu , Fenghua Wang , Jianhua Shi , Ji Feng Feng , Lin Shen , Shujun Yang , Xi-Chun Hu , Guanghai Dai , Nong Xu , Yi Jiang , Shu Yongqian , Qingyuan Zhang , Ye Chen , Xianglin Yuan , Xiaoyan Lin , Yi Ba , Qi Li , Wei Li , Haixin Huang , Sheng Yao

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02915432

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 116)

DOI

10.1200/JCO.2018.36.4_suppl.116

Abstract #

116

Poster Bd #

H20

Abstract Disclosures

Similar Posters

First Author: Rui-hua Xu

First Author: Xiuli Yang

First Author: Panpan Zhang

First Author: Li Zhou